跳至主要内容
临床试验/TCTR20170128001
TCTR20170128001已完成未知

Effect of prebiotic and probiotic mixture in the treatment of pediatric non-alcoholic fatty liver disease : A Double-blinded Randomized Controlled Trial.

The Ratchadaphiseksomphot Fund, Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 40 人开始时间: 2017年1月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Years 至 18 Years(—)
性别
All

入选标准

  • Obese children with NAFLD, age 6 to 18 years
  • - Obese is defined by weight more than 2SD in the same gender
  • and same age.
  • - NAFLD is defined by the presence of steatosis with controlled attenuation parameter (CAP) values ≥250 dB/m from Fibroscan with CAP.

排除标准

  • 1.Fatty liver from metabolic liver disease, viral hepatitis, Wilson disease, autoimmune hepatitis
  • 2.History of hepatotoxic drug or substance used
  • 3.Allergic or serious ADR to probiotics and prebiotics
  • 4.Poor compliance

研究者

发起方
The Ratchadaphiseksomphot Fund, Faculty of Medicine, Chulalongkorn University

相似试验

Effect of prebiotic and probiotic mixture in the... | 临床试验